questionsmedicales.fr
Composés chimiques organiques
Hydrocarbures
Hydrocarbures cycliques
Hydrocarbures aromatiques
Dérivés du benzène
Composés benzhydryliques
Orphénadrine
Orphénadrine : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Douleur musculaire
Évaluation clinique
Imagerie médicale
Analyses sanguines
Spasmes musculaires
Indications thérapeutiques
Raideur musculaire
Symptômes cliniques
Fibromyalgie
Traitement de la douleur
Symptômes
5
Effets secondaires
Somnolence
Réactions allergiques
Éruptions cutanées
Troubles de la vision
Effets indésirables
Palpitations
Difficultés respiratoires
Prévention
5
Prévention des douleurs
Exercices physiques
Alimentation équilibrée
Santé musculaire
Stress
Tensions musculaires
Étirements
Flexibilité musculaire
Repos
Récupération musculaire
Traitements
5
Administration orale
Comprimés
Posologie
Traitement médicamenteux
Interactions médicamenteuses
Consultation médicale
Avantages thérapeutiques
Soulagement de la douleur
Douleurs chroniques
Efficacité thérapeutique
Complications
5
Complications
Troubles cardiaques
Dépendance
Utilisation prolongée
Complications graves
Convulsions
Gestion des complications
Ajustement du traitement
Fonction hépatique
Tests de laboratoire
Facteurs de risque
5
Facteurs de risque
Âge avancé
Personnes âgées
Sensibilité aux médicaments
Alcool
Efficacité médicamenteuse
Antécédents médicaux
Maladies cardiaques
Femmes enceintes
Précautions médicamenteuses
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Orphénadrine : Questions médicales les plus fréquentes",
"headline": "Orphénadrine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Orphénadrine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-18",
"dateModified": "2025-03-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Orphénadrine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés benzhydryliques",
"url": "https://questionsmedicales.fr/mesh/D001559",
"about": {
"@type": "MedicalCondition",
"name": "Composés benzhydryliques",
"code": {
"@type": "MedicalCode",
"code": "D001559",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.115"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Orphénadrine",
"alternateName": "Orphenadrine",
"code": {
"@type": "MedicalCode",
"code": "D009966",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "L S Sorokina",
"url": "https://questionsmedicales.fr/author/L%20S%20Sorokina",
"affiliation": {
"@type": "Organization",
"name": "Petrovsky Russian Research Center of Surgery, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "D V Ryabova",
"url": "https://questionsmedicales.fr/author/D%20V%20Ryabova",
"affiliation": {
"@type": "Organization",
"name": "Petrovsky Russian Research Center of Surgery, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "A A Eremenko",
"url": "https://questionsmedicales.fr/author/A%20A%20Eremenko",
"affiliation": {
"@type": "Organization",
"name": "Petrovsky Russian Research Center of Surgery, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Shereen A Boltia",
"url": "https://questionsmedicales.fr/author/Shereen%20A%20Boltia",
"affiliation": {
"@type": "Organization",
"name": "Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt."
}
},
{
"@type": "Person",
"name": "Aya T Soudi",
"url": "https://questionsmedicales.fr/author/Aya%20T%20Soudi",
"affiliation": {
"@type": "Organization",
"name": "Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "How To Read a Network Meta-analysis.",
"datePublished": "2023-11-03",
"url": "https://questionsmedicales.fr/article/37925328",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.euf.2023.10.018"
}
},
{
"@type": "ScholarlyArticle",
"name": "Methodological quality of network meta-analysis in dentistry: a meta-research.",
"datePublished": "2023-07-10",
"url": "https://questionsmedicales.fr/article/37436290",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1807-3107bor-2023.vol37.0062"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of non-pharmacological interventions for adults with subjective cognitive decline: a network meta-analysis and component network meta-analysis.",
"datePublished": "2024-06-27",
"url": "https://questionsmedicales.fr/article/38937777",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12916-024-03491-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Network meta-interpolation: Effect modification adjustment in network meta-analysis using subgroup analyses.",
"datePublished": "2022-11-04",
"url": "https://questionsmedicales.fr/article/36283960",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jrsm.1608"
}
},
{
"@type": "ScholarlyArticle",
"name": "Treatments for alopecia areata: a network meta-analysis.",
"datePublished": "2023-10-23",
"url": "https://questionsmedicales.fr/article/37870096",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD013719.pub2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composés benzhydryliques",
"item": "https://questionsmedicales.fr/mesh/D001559"
},
{
"@type": "ListItem",
"position": 8,
"name": "Orphénadrine",
"item": "https://questionsmedicales.fr/mesh/D009966"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Orphénadrine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Orphénadrine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Orphénadrine",
"description": "Comment diagnostiquer une douleur musculaire nécessitant l'orphénadrine ?\nQuels tests sont utiles avant de prescrire l'orphénadrine ?\nL'orphénadrine est-elle indiquée pour tous les types de douleurs ?\nQuels signes cliniques justifient l'utilisation de l'orphénadrine ?\nL'orphénadrine est-elle utilisée en cas de fibromyalgie ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Network+Meta-Analysis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Orphénadrine",
"description": "Quels sont les effets secondaires courants de l'orphénadrine ?\nL'orphénadrine peut-elle provoquer des réactions allergiques ?\nQuels symptômes indiquent une surdose d'orphénadrine ?\nL'orphénadrine peut-elle causer des troubles de la vision ?\nQuels symptômes nécessitent l'arrêt immédiat de l'orphénadrine ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Network+Meta-Analysis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Orphénadrine",
"description": "Comment prévenir les douleurs nécessitant l'orphénadrine ?\nL'alimentation joue-t-elle un rôle dans la prévention des douleurs musculaires ?\nLe stress peut-il aggraver les douleurs musculaires ?\nDes étirements réguliers peuvent-ils prévenir les douleurs ?\nLe repos est-il important pour prévenir les douleurs musculaires ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Network+Meta-Analysis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Orphénadrine",
"description": "Comment l'orphénadrine est-elle administrée ?\nQuelle est la posologie standard de l'orphénadrine ?\nL'orphénadrine peut-elle être combinée avec d'autres médicaments ?\nQuels sont les avantages de l'orphénadrine par rapport à d'autres traitements ?\nL'orphénadrine est-elle efficace contre les douleurs chroniques ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Network+Meta-Analysis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Orphénadrine",
"description": "Quelles complications peuvent survenir avec l'orphénadrine ?\nL'orphénadrine peut-elle entraîner une dépendance ?\nQuels signes indiquent une complication grave de l'orphénadrine ?\nComment gérer les complications liées à l'orphénadrine ?\nL'orphénadrine peut-elle affecter la fonction hépatique ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Network+Meta-Analysis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Orphénadrine",
"description": "Quels facteurs augmentent le risque d'effets secondaires de l'orphénadrine ?\nLes personnes âgées sont-elles plus sensibles à l'orphénadrine ?\nL'usage d'alcool influence-t-il l'efficacité de l'orphénadrine ?\nLes antécédents médicaux influencent-ils l'utilisation de l'orphénadrine ?\nLes femmes enceintes peuvent-elles prendre de l'orphénadrine ?",
"url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Network+Meta-Analysis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une douleur musculaire nécessitant l'orphénadrine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et l'historique des symptômes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utiles avant de prescrire l'orphénadrine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie et des analyses sanguines peuvent être réalisés pour évaluer l'état musculaire."
}
},
{
"@type": "Question",
"name": "L'orphénadrine est-elle indiquée pour tous les types de douleurs ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est principalement indiquée pour les douleurs musculaires et les spasmes."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques justifient l'utilisation de l'orphénadrine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs aiguës, des spasmes et une raideur musculaire."
}
},
{
"@type": "Question",
"name": "L'orphénadrine est-elle utilisée en cas de fibromyalgie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être utilisée pour soulager certains symptômes de la fibromyalgie."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants de l'orphénadrine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent la sécheresse buccale, la somnolence et des vertiges."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle provoquer des réactions allergiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions allergiques comme des éruptions cutanées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surdose d'orphénadrine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent confusion, hallucinations et tachycardie."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle causer des troubles de la vision ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner une vision floue ou des troubles visuels temporaires."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent l'arrêt immédiat de l'orphénadrine ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des palpitations, des éruptions cutanées ou des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Comment prévenir les douleurs nécessitant l'orphénadrine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exercices réguliers, une bonne posture et des pauses fréquentes peuvent aider."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention des douleurs musculaires ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut contribuer à la santé musculaire."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver les douleurs musculaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les tensions musculaires et les douleurs."
}
},
{
"@type": "Question",
"name": "Des étirements réguliers peuvent-ils prévenir les douleurs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les étirements réguliers aident à maintenir la flexibilité et à prévenir les douleurs."
}
},
{
"@type": "Question",
"name": "Le repos est-il important pour prévenir les douleurs musculaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un repos adéquat est essentiel pour la récupération musculaire."
}
},
{
"@type": "Question",
"name": "Comment l'orphénadrine est-elle administrée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est généralement administrée par voie orale sous forme de comprimés."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie standard de l'orphénadrine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie standard est de 100 mg deux fois par jour, selon les besoins."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle être combinée avec d'autres médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il est important de consulter un médecin pour éviter les interactions."
}
},
{
"@type": "Question",
"name": "Quels sont les avantages de l'orphénadrine par rapport à d'autres traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle offre un soulagement rapide des spasmes musculaires et des douleurs."
}
},
{
"@type": "Question",
"name": "L'orphénadrine est-elle efficace contre les douleurs chroniques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être efficace pour certaines douleurs chroniques, mais pas pour toutes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'orphénadrine ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des troubles cardiaques ou des problèmes neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle entraîner une dépendance ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle a un faible potentiel de dépendance, mais une utilisation prolongée doit être surveillée."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave de l'orphénadrine ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des douleurs thoraciques, des évanouissements ou des convulsions."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à l'orphénadrine ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est crucial de consulter un médecin pour ajuster le traitement ou changer de médicament."
}
},
{
"@type": "Question",
"name": "L'orphénadrine peut-elle affecter la fonction hépatique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests de la fonction hépatique peuvent être nécessaires en cas d'utilisation prolongée."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'effets secondaires de l'orphénadrine ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies préexistantes et l'utilisation d'autres médicaments augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus sensibles à l'orphénadrine ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets secondaires de l'orphénadrine."
}
},
{
"@type": "Question",
"name": "L'usage d'alcool influence-t-il l'efficacité de l'orphénadrine ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'alcool peut augmenter les effets sédatifs de l'orphénadrine."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils l'utilisation de l'orphénadrine ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies cardiaques ou neurologiques peuvent limiter son utilisation."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes peuvent-elles prendre de l'orphénadrine ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'orphénadrine doit être utilisée avec prudence chez les femmes enceintes, après avis médical."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 15/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Petrovsky Russian Research Center of Surgery, Moscow, Russia.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Petrovsky Russian Research Center of Surgery, Moscow, Russia.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Petrovsky Russian Research Center of Surgery, Moscow, Russia.
Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt.
Publications dans "Orphénadrine" :
2 publications dans cette catégorie
Affiliations :
Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Peoples' Friendship University of Russia, Moscow, Russia.
City Clinical Hospital No. 24, Moscow, Russia.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Peoples' Friendship University of Russia, Moscow, Russia.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Peoples' Friendship University of Russia, Moscow, Russia.
City Clinical Hospital No. 24, Moscow, Russia.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute for Nanotechnology and Water Sustainability, College of Science, Engineering and Technology, University of South Africa, Florida Science Campus, Roodepoort, 1710, South Africa.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Institute of Analytical and General Chemistry, Johannes Kepler University, Altenberger Strasse 69, 4040, Linz, Austria. christian.klampfl@jku.at.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Department of Tropical medicine, Faculty of Medicine, Tanta University.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Department of Tropical medicine, Faculty of Medicine, Tanta University.
Publications dans "Orphénadrine" :
1 publication dans cette catégorie
Affiliations :
Department of Public health, Menofia University, Egypt.
Publications dans "Orphénadrine" :
Network meta-analysis (NMA) expands upon traditional meta-analysis by integrating three or more interventions. This allows comparing interventions using evidence from trials that have compared pairs o...
This meta-research aimed to provide an overview of the methodological quality and risk of bias of network meta-analyses (NMA) in dentistry. Searches for NMA of randomized clinical trials with clinical...
Non-pharmacological interventions have a myriad of available intervention options and contain multiple components. Whether specific components of non-pharmacological interventions or combinations are ...
PubMed, Embase, Cochrane, CINAHL, PsycINFO, CENTRAL, Web of Science, and China's two largest databases, CNKI and Wanfang, were searched from inception to 22nd, January 2023. Randomized controlled tria...
A total of 39 trials with 2959 patients were included (range of mean ages, 58.79-77.41 years). Resistance exercise might be the optimal intervention for reducing memory complaints in adults with subje...
The form of physical activity performed appears to be more beneficial than cognitive interventions in reducing subjective memory complaints for adults with subjective cognitive decline, and this diffe...
PROSPERO registry number. CRD42022355363....
Effect modification (EM) may cause bias in network meta-analysis (NMA). Existing population adjustment NMA methods use individual patient data to adjust for EM but disregard available subgroup informa...
Alopecia areata is an autoimmune disease leading to nonscarring hair loss on the scalp or body. There are different treatments including immunosuppressants, hair growth stimulants, and contact immunot...
To assess the benefits and harms of the treatments for alopecia areata (AA), alopecia totalis (AT), and alopecia universalis (AU) in children and adults....
The Cochrane Skin Specialised Register, CENTRAL, MEDLINE, Embase, ClinicalTrials.gov and WHO ICTRP were searched up to July 2022....
We included randomised controlled trials (RCTs) that evaluated classical immunosuppressants, biologics, small molecule inhibitors, contact immunotherapy, hair growth stimulants, and other therapies in...
We used the standard procedures expected by Cochrane including assessment of risks of bias using RoB2 and the certainty of the evidence using GRADE. The primary outcomes were short-term hair regrowth ...
We included 63 studies that tested 47 different treatments in 4817 randomised participants. All trials used a parallel-group design except one that used a cross-over design. The mean sample size was 7...
We found that treatment with baricitinib results in an increase in short- and long-term hair regrowth compared to placebo. Although we found inconclusive results for the risk of serious adverse effect...
Network meta-analysis combines direct and indirect evidence to compare multiple treatments. As direct evidence for one treatment contrast may be indirect evidence for other treatment contrasts, biases...
Evidence has shown that private industry-sponsored randomized controlled trials (RCTs) and meta-analyses are more likely to report intervention-favourable results compared with other sources of fundin...
To (a) explore the recommendation rate of industry-sponsored NMAs on their company's intervention, and (b) assess reporting in NMAs of pharmacologic interventions according to their funding type....
Design: Scoping review of published NMAs with RCTs....
We used a pre-existing NMA database including 1,144 articles from MEDLINE, EMBASE and Cochrane Database of Systematic Reviews, published between January 2013 and July 2018....
NMAs with transparent funding information and comparing pharmacologic interventions with/without placebo....
We captured whether NMAs recommended their own or another company's intervention, classified NMAs according to their primary outcome findings (i.e., statistical significance and direction of effect), ...
We retrieved 658 NMAs, which reported a median of 23 items in the PRISMA-NMA checklist (interquartile range [IQR]: 21-26). NMAs were categorized as 314 publicly-sponsored (PRISMA-NMA median 24.5, IQR ...
Differences in completeness of reporting and author characteristics were apparent among NMAs with different types of funding. Publicly-sponsored NMAs had the best reporting and published their finding...
Therapy for myasthenia gravis (MG) is undergoing a profound change, with new treatments being tested. These include complement inhibitors and neonatal Fc receptor (FcRn) blockers. The aim of this stud...
We assessed statistical heterogeneity across trials based on the Cochrane Q test and I...
We observed an overall mean Myasthenia Gravis-Activities of Daily Living scale (MG-ADL) score change of -2.17 points (95% confidence interval [CI] -2.67, -1.67; p < 0.001) as compared to placebo. No s...
Anti-complement and FcRn treatments both proved to be effective in MG patients, whereas rituximab did not show a significant benefit for patients. Within the limitations of this meta-analysis, includi...
Aerobic exercise is widely recognized for improving mental health and reducing negative emotions, including anxiety. However, research on its role in preventing and treating postpartum depression (PPD...
We conducted a quantitative systematic review of the study in 5 representative databases for the effect of aerobic exercise on PPD. Meta-analysis and network meta-analysis were performed with Review-M...
Twenty-six studies with 2,867 participants were eventually included and the efficacy of aerobic exercise in preventing and treating postpartum depression is significant compared to standard care. (MD ...
The efficacy of aerobic exercise in preventing and treating postpartum depression is significant compared to standard care, with a greater emphasis on prevention. The optimal prescribed exercise volum...
Mounting evidence suggests that breast reduction surgery displays higher rates of surgical site infections (SSI) than initially presumed. Objective of this network meta-analysis is to evaluate the eff...
A network meta-analysis was conducted using a predetermined protocol after searching the electronic databases MEDLINE, Scopus, the Cochrane Library and US National Institutes of Health Ongoing Trials ...
A total of 10 studies was included in the analysis involving 1331 patients. All but one study controlled for major risk factors, and no differences were observed in patients' baseline characteristics....
Antibiotics mitigate the SSI rate after breast reduction. This meta-analysis provides an evidence-based strategy to optimize antibiotic administration. Further research is needed though to examine ant...
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Inst...